On May 3, 2022 HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, reported that HOOKIPA’s management team will participate in and present at the following upcoming investor conferences (Press release, Hookipa Pharma, MAY 3, 2022, View Source [SID1234613365]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BofA Securities 2022 Healthcare Conference, May 10-13, Las Vegas
Fireside Chat: May 10, 8:40am PT
2022 RBC Capital Markets Global Healthcare Conference, May 17-18, New York
Fireside Chat: May 17, 4:05pm ET
H.C. Wainwright Global Investment Conference, May 23-26, Miami Beach
Fireside Chat: May 24, 2:00pm ET
Webcasts will be available within the Investors & Media section of HOOKIPA’s website at View Source Archived replays will be accessible for 30 days following each event.